Synthesis of potential bisubstrate inhibitors of Leishmania elongating α-D-mannosyl phosphate transferase

Tetrahedron Letters

Volumn 45, Issue 4, 2004, Pages 857-862

  Borodkin, Vladimir S ^a   Ferguson, Michael A J ^a   Nikolaev, Andrei V ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Carbohydrates; Phosphonic acids and derivatives; Transition states

Indexed keywords

ALPHA DEXTRO MANNOSYL PHOSPHATE TRANSFERASE; ENZYME INHIBITOR; GUANOSINE; MANNOSE; MEDRONIC ACID; PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BINDING; COVALENT BOND; DRUG SYNTHESIS; LEISHMANIA; NONHUMAN; STEREOCHEMISTRY;

EID: 0346787845     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2003.11.022     Document Type: Article

References (27)

1. (a) Turco S.J., Spath G.F., Beverley S.M. Trends Parasitol. 17:2001;223-226
2. (b) Ilg T. Parasitol. Today. 16:2000;489-497.
3. (a) Carver M.A., Turco S.J. J. Biol. Chem. 266:1991;10974-10981
4. (b) Carver M.A., Turco S.J. Arch. Biochem. Biophys. 295:1992;309-317.
5. Routier F.H., Higson A.P., Ivanova I.A., Ross A.J., Tsvetkov Y.E., Yashunsky D.V., Bates P.A., Nikolaev A.V., Ferguson M.A.J. Biochemistry. 39:2000;8017-8025.
6. For the definition of the bisubstrate inhibition concept: Palcic M., Heerze L., Srivastava O.P., Hindsgaul O. J. Biol. Chem. 264:1989;17174-17181. For recent advances in this area: Hinou H., Sun X.-L., Ito Y. Tetrahedron Lett. 43:2002;9147-9150. and references cited therein.
7. For the definition of the bisubstrate inhibition concept: Palcic M., Heerze L., Srivastava O.P., Hindsgaul O. J. Biol. Chem. 264:1989;17174-17181. For recent advances in this area: Hinou H., Sun X.-L., Ito Y. Tetrahedron Lett. 43:2002;9147-9150. and references cited therein.
8. Borodkin V.S., Ferguson M.A.J., Nikolaev A.V. Tetrahedron Lett. 42:2001;5305-5308.
9. Borodkin V.S., Milne F.C., Ferguson M.A.J., Nikolaev A.V. Tetrahedron Lett. 43:2002;7821-7825.
10. Van der Klein P.M.A., Dreef C.E., van der Marel G.A., van Boom J.H. Tetrahedron Lett. 30:1989;5473-5476.
11. All new compounds showed satisfactory analytical and spectral data.
12. 22 +15.2° ( c 0.5, MeOH).
13. +) in MeOH and concentration. The triester 10 (which contained up to 10% of the symmetric dimethyl ester) was used without additional purification.
14. Malachowski W.P., Coward J.K. J. Org. Chem. 59:1994;7616-7624.
15. Campbell D.A., Bermack J.C. J. Org. Chem. 59:1994;658-660.
16. 2O, 1:1).
17. Turner J.J., Filipov D.V., Overhand M., van der Marel G.A., van Boom J.A. Tetrahedron Lett. 42:2001;5763-5767 Vincent S.P., Mioskowski C., Lebeau L. Nucleos. Nucleot. 18:1999;2127-2139.
18. Turner J.J., Filipov D.V., Overhand M., van der Marel G.A., van Boom J.A. Tetrahedron Lett. 42:2001;5763-5767 Vincent S.P., Mioskowski C., Lebeau L. Nucleos. Nucleot. 18:1999;2127-2139.
19. Routier F.H., Nikolaev A.V., Ferguson M.A.J. Glycoconjugate J. 16:2000;773-780.
20. For the regioselective monodeprotection of the nucleoside- methylenebisphosphonate tribenzyl ester derivative: Ikeda H., Abushanab E., Marquez V.E. Bioorg. Med. Chem. Lett. 9:1999;3069-3074.
21. Daub G.W., Van Tamelen E.E. J. Am. Chem. Soc. 99:1977;3526-3528.
22. (a) Creary X. Org. Synth. 64:1985;207-216
23. (b) Liotta L.J., Ganem B. Tetrahedron Lett. 30:1989;4759-4762.
24. Saady M., Lebeau L., Mioskowski C. Helv. Chim. Acta. 78:1995;670-678.
25. 2NCOCl-DIPEA in pyridine (rt, 16 h, 50%) prior to desilylation with TBAF-AcOH in THF (rt, 1 h, 90%).
26. 2O as recommended in Ref. [14b].
27. 2O, 1:1).